Connaught House
1 Burlington Road Dublin 4
Dublin D04 C5Y6
Ireland
353 1 772 8000
https://www.alkermes.com
Setor(es): Healthcare
Indústria: Drug Manufacturers - Specialty & Generic
Funcionários Integrais: 2.100
Nome | Título | Pagar | Exercido | Nascido em |
---|---|---|---|---|
Mr. Richard F. Pops | Chairman & CEO | 2,61M | N/A | 1962 |
Mr. Blair C. Jackson | Interim Principal Financial Officer, Executive VP, Chief Risk Officer & COO | 1,17M | N/A | 1973 |
Mr. David Joseph Gaffin | Executive VP, Chief Legal Officer, Chief Compliance Officer & Secretary | 1,15M | N/A | 1972 |
Mr. Iain Michael Brown | Senior VP & CFO (Leave of Absence) | 950,88k | N/A | 1969 |
Dr. Craig C. Hopkinson M.D. | Executive VP of Research & Development and Chief Medical Officer | 1,24M | N/A | 1968 |
Dr. Floyd E. Bloom M.D. | Founder | 57,73k | N/A | 1937 |
Mr. Samuel J. Parisi | Interim Principal Accounting Officer & VP of Finance | N/A | N/A | 1975 |
Mr. Thomas Harvey | Chief Information Officer & Senior VP of IT | N/A | N/A | N/A |
Ms. Sandra Coombs | Senior Vice President of Corporate Affairs & Investor Relations | N/A | N/A | N/A |
Mr. Stephen Schiavo | Senior Vice President of Human Resources | N/A | N/A | N/A |
O QualityScore de governança da ISS da Alkermes plc a partir de 1 de abril de 2024 é 3. As principais pontuações para Auditoria são: 1; Conselho: 6; Direitos de Acionistas: 3; Compensação: 4.